Aptus Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
12,480
+1,098
| +10% | +$118K | 0.01% | 469 |
|
|
2025
Q1 | $1.15M | Sell |
11,382
-310
| -3% | -$31.3K | 0.01% | 480 |
|
|
2024
Q4 | $1.04M | Buy |
11,692
+1,723
| +17% | +$154K | 0.01% | 487 |
|
|
2024
Q3 | $835K | Buy |
9,969
+520
| +6% | +$43.6K | 0.01% | 443 |
|
|
2024
Q2 | $728K | Buy |
9,449
+1,639
| +21% | +$126K | 0.01% | 437 |
|
|
2024
Q1 | $535K | Buy |
7,810
+1,149
| +17% | +$78.7K | 0.01% | 493 |
|
|
2023
Q4 | $385K | Buy |
6,661
+142
| +2% | +$8.21K | 0.01% | 424 |
|
|
2023
Q3 | $344K | Buy |
+6,519
| New | +$344K | 0.01% | 444 |
|
|
2022
Q4 | – | Sell |
-64,563
| Closed | -$2.5M | – | 803 |
|
|
2022
Q3 | $2.5M | Sell |
64,563
-23,683
| -27% | -$917K | 0.06% | 180 |
|
|
2022
Q2 | $3.29M | Sell |
88,246
-490
| -0.6% | -$18.3K | 0.09% | 125 |
|
|
2022
Q1 | $3.93M | Buy |
+88,736
| New | +$3.93M | 0.1% | 110 |
|
|
2019
Q2 | – | Sell |
-68,767
| Closed | -$2.64M | – | 324 |
|
|
2019
Q1 | $2.64M | Buy |
+68,767
| New | +$2.64M | 0.45% | 41 |
|